Wu, D., Zhao, S., Wang, X., Wang, H., Zhao, J., Wang, J., Xue, B., Luo, W., Li, M., Zhang, M., Wang, M., Xi, J., Liu, H., Sun, C., Liu, R., Fan, X. F., Lv, Y., He, P. (2026). REVO-U: A next-generation, gene-editing–free universal CAR-T platform to enable ultra–high-yield manufacturing and identification of early clinical activity in relapsed/refractory DLBCL.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.7013